NFKB1 and cancer: The underlying inflammation due to the presence of a tumor leads to aberrant NF-κB activation and promotes cancer invasion and metastasis, and such a phenomenon has been observed in many tumor types, including lung cancer, breast cancer, and glioma (17–19).